Press releases Year None202220212020201920182017201620152014 Dec 22, 2022 Otonomy Announces Change in Stock Exchange Listing Dec 19, 2022 Otonomy Provides Corporate Update Nov 10, 2022 Otonomy Reports Third Quarter 2022 Financial Results and Provides Corporate Update Oct 13, 2022 Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss Aug 01, 2022 Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus Jul 25, 2022 Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update Jul 18, 2022 Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate Update May 18, 2022 Otonomy to Participate in the H.C. Wainwright Global Investment Conference May 12, 2022 Otonomy Announces OTO-825 Presentation at the American Society of Gene & Cell Therapy Annual Meeting May 09, 2022 Otonomy Reports First Quarter 2022 Financial Results and Provides Corporate Update Pagination Current page 1 Page 2 Page 3 Next page next › Last page last »
